Investor Relations SIXNYSE SIX: ALC CHF73.42 +0.64 ( 0.88% ) Pricing delayed by 20 minutes Last Updated 12/03/2021 3:49 PM Corporate Overview Alcon is the world leader in eye care, dedicated to helping people see brilliantly. With our 70-plus-year heritage, we are the largest eye care device company in the world – with complementary businesses in Surgical and Vision Care. Our business is built on a solid foundation of market-leading eye care expertise and deep, long-standing relationships with eye care professionals. Alcon is leading in eye care innovation and is well positioned for growth in an expanding global marketplace. We have a long history of industry firsts, based on deep capabilities in materials science, surface chemistry and optics. Our strong pipeline includes more than 100 projects in process and more than 1,200 associates worldwide researching and developing treatments for vision conditions and eye diseases. World Leader In Vision Care $7B Sales growing eye care device leader 80% Of visual impairment is preventable or curable1 $269B Costs of productivity loss associated with vision impairment due to uncorrected myopia and presbyopia1 140+ Countries served by over 23,000 employees 100+ Pipeline products under development and 1,400 associates working in R&D 400+ Years of healthcare experience behind strong management team Note: Numbers are rounded for presentation purposes and based on 2020 sales 1. World Health Organization (WHO), www.who.int/blindness LEARN MORE Latest News 11/09/2021 Alcon Reports Third Quarter 2021 Results READ MORE 11/08/2021 Alcon to Acquire Ivantis, Inc. and its Hydrus Microstent for Surgical Glaucoma, Strengthening Global Ophthalmology Portfolio READ MORE 08/17/2021 Alcon Reports Second Quarter 2021 Results READ MORE VIEW ALL NEWS Why Invest Loading... Latest Quarterly Reports Loading latest financials... VIEW ALL FINANCIAL REPORTS Upcoming Events Loading ... VIEW ALL EVENTS Contact Alcon Investor Relations +41 589 112 110 +1 817 615 2789 investor.relations@alcon.com Computershare Switzerland: +41 62 205 77 00 U.S. Toll Free: +1 800 736 3001 International: +1 781 575 3100 Quick Links SEC FILINGS INVESTOR FAQS INFORMATION REQUEST FORM SPIN OFF Investor Email Alerts News Events & Presentations Quarterly Reports Annual Reports SEC Filings End of Day Stock Quote Consensus Estimates ESG UNSUBSCRIBE Contact Us See Brilliantly Privacy Policy Cookies Policy Terms of Use California Resident? Do Not Sell My Personal Information Powered By Q4 Inc. 5.66.0.1 (opens in new window) Our Use of Cookies We use cookies that are strictly necessary to make our site work. We would also like to set optional cookies for the purposes of improving site content, personalizing content, tailoring advertising to your interests, and measuring site usage. By clicking "Accept and Continue" you are agreeing to the use of these cookies. Alternately, you can customize the cookies by clicking on "Manage Cookie Settings". For more information on our use of cookies, please visit our Cookie Notice page. ACCEPT & CONTINUE MANAGE COOKIE SETTINGS